Minimal disease detection in patients with alveolar rhabdomyosarcoma using a reverse transcriptase-polymerase chain reaction method

Cancer

Volumn 78, Issue 6, 1996, Pages 1320-1327

  Kelly, Kara M ^a   Womer, Richard B ^a   Barr, Frederic G ^b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

minimal disease detection; pediatric oncology; reverse transcriptase polymerase chain reaction; rhabdomyosarcoma; tumor specific translocation

Indexed keywords

GENE PRODUCT; RNA;

ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW EXAMINATION; BONE MARROW PURGING; CANCER STAGING; CHROMOSOME 13; CHROMOSOME TRANSLOCATION 1; CHROMOSOME TRANSLOCATION 2; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; FOLLOW UP; GENE FUSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; RELAPSE; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; TREATMENT OUTCOME;

BONE MARROW; BONE MARROW PURGING; BONE TRANSPLANTATION; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 13; DNA-BINDING PROTEINS; FEASIBILITY STUDIES; FOLLOW-UP STUDIES; FORKHEAD TRANSCRIPTION FACTORS; HOMEODOMAIN PROTEINS; HUMANS; MUSCLE PROTEINS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NERVE TISSUE PROTEINS; PAIRED BOX TRANSCRIPTION FACTORS; PAX7 TRANSCRIPTION FACTOR; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; REMISSION INDUCTION; RHABDOMYOSARCOMA, ALVEOLAR; RNA, NEOPLASM; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSLOCATION, GENETIC; TREATMENT OUTCOME;

EID: 0029810867     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960915)78:6<1320::AID-CNCR22>3.0.CO;2-1     Document Type: Article

References (27)

1. Raney RB, Hays DM, Tefft M, Triche T. Rhabdomyosarcoma and the undifferentiated sarcomas. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. 2nd ed. Philadelphia: J.B. Lippincott, 1993:769-94.
2. Tsokos M, Webber BL, Parham DM, Wesley RA, Miser A, Miser JS, et al. Rhabdomyosarcoma, a new classification scheme related to prognosis. Arch Pathol Lab Med 1992; 116:847-55.
3. Fey MF, Kulozik AE, Hansen-Hagge TE, Toble A. The polymerase chain reaction: a new tool for the detection of minimal residual disease in haematological malignancies. Eur J Cancer 1991;27:89-94.
4. Barr FG, Galili N, Holick J, Biegel JA, Rovera G, Emanuel BS. Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nature Genet 1993;3:113-7.
5. Galili N, Davis RJ, Fredericks WJ, Mukhopadhyay S, Rauscher FJ III, Emanuel BS, et al. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nature Genet 1993;5:230-5.
6. Shapiro DN, Sublett JE, Li B, Downing JR, Naeve CW. Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res 1993;53:5108-12.
7. Douglass EC, Rowe ST, Valentine M, Parham DM, Berkow R, Bowman WP, et al. Variant translocations of chromosome 13 in alveolar rhabdomyosarcoma. Genes Chromosom Cancer 1991;3:480-2.
8. Biegel JA, Meek RS, Parmiter AH, Conard K, Emanuel BS. Chromosomal translocation t(1;13)(p36;q14) in a case of rhabdomyosarcoma. Genes Chromosom Cancer 1991;3:483-4.
9. Whang-Peng J, Knutsen T, Theil K, Horowitz ME, Triche T. Cytogenetic studies in subgroups of rhabdomyosarcoma. Genes Chromosom Cancer 1992;5:299-310.
10. Davis RJ, D'Cruz CM, Lovell MA, Biegel JA, Barr FG. Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res 1994; 54:2869-72.
11. Barr FG, Chatten J, D'Cruz CM, Wilson AE, Nauta LE, Nycum LM, et al. Molecular assays for chromosomal translocations in the diagnosis of pediatric soft tissue sarcomas. JAMA 1995;273:553-7.
12. Dockhorn-Dworniczak B, Pfleiderer C, Schafer KL, Zoubek A, Burdach S, Hoffmann C, et al. Molecular staging of Ewing's tumor patients using RT-PCR analysis of blood and bone marrow samples (abstr 1418). Proc Am Soc Clin Oncol 1995;14:444.
13. Dockhorn-Dworniczak B, Schafer K-L, Dantcheva R, Blasius S, Winkelmann W, Strehl S, et al. Diagnostic value of the molecular genetic detection of the t(11;22) translocation in Ewing's tumours. Virchows Archiv 1994;425:107-12.
14. Peter M, Magdelenat H, Michon J, Melot T, Oberlin O, Zucker JM, et al. Sensitive detection of occult Ewing's cells by the reverse transcriptase-polymerase chain reaction. Br J Cancer 1995;72:96-100.
15. Toretsky JA, Neckers L, Wexler LH. Detection of (11;22)(q24;q12) translocation-bearing cells in the peripheral blood progenitor cells of patients with Ewing's sarcoma family of tumors. J Natl Cancer Inst 1995;87:385-6.
16. Pfleiderer C, Zoubek A, Gruber B, Kronberger M, Ambros PF, Lion T, et al. Detection of tumour cells in peripheral blood and bone marrow from Ewing tumour patients by RT-PCR. Int J Cancer 1995;64:135-9.
17. Barr FG, Xiong QB, Kelly KM. A consensus polymerase chain reaction-oligonucleotide hybridization approach for the detection of chromosomal translocations in pediatric bone and soft tissue sarcomas. Am J Clin Pathol 1995;104:627-33.
18. Maurer HM, Beltangady M, Gehan EA, Crist W, Hammond D, Hays DM, et al. The Intergroup Rhabdomyosarcoma Study-I, a final report. Cancer 1988;61:209-20.
19. Ruymann FB, Newton WA Jr., Ragab AH, Donaldson MH, Foulkes M. Bone marrow metastases at diagnosis in children and adolescents with rhabdomyosarcoma. Cancer 1984;53: 368-73.
20. Maurer HM, Gehan EA, Beltangady M, Crist W, Dickman PS, Donaldson SS, et al. The Intergroup Rhabdomyosarcoma Study-II. Cancer 1993;71:1904-22.
21. Reilly A, Perilongo G, Womer R, Chatten J, Jarrett P. Histologic subtype determines pattern of metastases in childhood rhabdomyosarcoma (abstr 1111). Proc Am Soc Clin Oncol 1991;10:316.
22. Brenner MK, Rill DR, Moen RC, Krance RA, Mirro J Jr., Anderson WF, et al. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 1993;341:85-6.
23. Rill DR, Buschle M, Foreman NK, Bartholomew C, Moen RC, Santana VM, et al. Retrovirus mediated gene transfer as an approach to analyze neuroblastoma relapse after autologous bone marrow transplantation. Hum Gene Ther 1992;3:129-36.
24. Gribben JG, Freedman AS, Neuberg D, Roy DC, Blake KW, Woo SD, et al. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 1991;325:1525-33.
25. Horowitz ME, Kinsella TJ, Wexler LH, Belasco J, Triche T, Tsokos M, et al. Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma. J Clin Oncol 1993;11:1911-8.
26. Martens ACM, Schultz FW, Hagenbeek A. Nonhomogeneous distribution of leukemia in the bone marrow during minimal residual disease. Blood 1987;70:1073-8.
27. Campana D, Pui C-H. Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. Blood 1995;85:1416-34.